Jane Street’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Jane Street’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-21,083	Closed	-$2K	–	6040
2018 Q4	$2K	Buy	+21,083	New	+$13.8K	﹤0.01%	4842
2018 Q2	–	Sell	-46,232	Closed	-$79.9K	–	5973
2018 Q1	$85K	Buy	46,232 +12,645	+38%	+$26.7K	﹤0.01%	4627
2017 Q4	$75K	Sell	33,587 -163,389	-83%	-$406K	﹤0.01%	4377
2017 Q3	$571K	Buy	196,976 +167,985	+579%	+$573K	﹤0.01%	2945
2017 Q2	$129K	Buy	+28,991	New	+$120K	﹤0.01%	4126
2016 Q4	–	Sell	-38,660	Closed	-$213K	–	4877
2016 Q3	$213K	Buy	+38,660	New	+$181K	﹤0.01%	3657
2015 Q4	–	Sell	-63,128	Closed	-$335K	–	4694
2015 Q3	$335K	Sell	63,128 -13,548	-18%	-$105K	﹤0.01%	2687
2015 Q2	$636K	Buy	+76,676	New	+$372K	﹤0.01%	2049
2014 Q3	–	Sell	-11,900	Closed	-$48K	–	3311
2014 Q2	$48K	Sell	11,900 -9,808	-45%	-$41.7K	﹤0.01%	2431
2014 Q1	$115K	Buy	+21,708	New	+$122K	﹤0.01%	2493

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Jane Street's SGYP Position: Q1 2019 in Review

Jane Street sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 21,083 shares — an estimated $2K sold.

Jane Street first reported a position in SGYP in Q1 2014 and held it in 10 quarters. The position peaked at $636K in Q2 2015. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

Jane Street reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
Jane Street sold 21,083 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $2K.
Jane Street first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2014 and held it in 10 quarters.
Jane Street's Synergy Pharmaceuticals, Inc Common Stock position peaked at $636K in Q2 2015.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Jane Street's 13F filing for Q1 2019, filed 16 May 2019.